Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Expression, purification, crystallization and preliminary X-ray crystallographic analysis of the extracellular olfactomedin domain of gliomedin.
[Therapeutic plasma exchange: applications in neurology].
Ethical considerations when counseling patients about stem cell tourism.
[Current description of multiple sclerosis].
The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
PEGylated IFNβ-1a in the treatment of multiple sclerosis.
Psychiatric co-morbidity in multiple sclerosis: The risk of depression and anxiety before and after MS diagnosis.
Initial investigation of the blood-brain barrier in MS lesions at 7 tesla.
Sunshine and multiple sclerosis.
Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
Aquaporin and brain diseases.
Interferon beta-1a for multiple sclerosis: old drug, new clothes.
Sexual function in women with multiple sclerosis.
Sexual dysfunction in women with multiple sclerosis: Dimensions and contributory factors.
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?
Wavelet-Based Scalar-on-Function Finite Mixture Regression Models.
Elevated Lipid Profiles in Patients with Acute Transverse Myelitis.
Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Axon-glia interaction and membrane traffic in myelin formation.
Determinant spreading and the dynamics of the autoimmune T-cell repertoire.
Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
A pain-mediated neural signal induces relapse in murine autoimmune encephalomyelitis, a multiple sclerosis model.
Characterization of anti-natalizumab antibodies in multiple sclerosis patients.
Historical changes of seasonal differences in the frequency of multiple sclerosis clinical attacks: a multicenter study.

Pages